Search
for
Sort by
Research 30 of 169
- Trichomegaly of the eyelashes following treatment with cetuximab
- Efficacy and Skin Toxicity Management with Cetuximab in Metastatic Colorectal Cancer: Outcomes from an Oncologic/Dermatologic Cooperation
- Fatal Toxic Epidermal Necrolysis Associated With Cetuximab in a Patient With Colon Cancer
- Cetuximab-Associated Elongation of the Eyelashes
- Incidence and management of cutaneous toxicities associated with cetuximab
- Cetuximab-induced hypertrichosis of the scalp and eyelashes
- Adverse Reaction to Cetuximab, an Epidermal Growth Factor Receptor Inhibitor.
- Hypertrichosis, trichomegaly, and androgenic alopecia related to cetuximab treatment
- Cetuximab Induced Hidrocystomas: A Case Report
- Response of Cutaneous Squamous Cell Carcinoma to Treatment With Cetuximab
- BAYONET trial: staged combination with encorafenib, binimetinib, plus cetuximab following encorafenib plus cetuximab for BRAF V600E-mutant metastatic colorectal cancer
- Anti-EGFR mechanism of action: antitumor effect and underlying cause of adverse events.
- Perifollicular Xanthomas Associated with Epidermal Growth Factor Receptor Inhibitor Therapy
- Histopathologic features of erythematous papulopustular eruption to epidermal growth factor receptor inhibitors in cancer patients
- Treatment of Cultured Sebocytes with an EGFR Inhibitor Does Not Lead to Significant Upregulation of Inflammatory Biomarkers
- ASSESSMENT OF SOCIODEMOGRAPHIC CHARACTERISTICS AND COMPARATIVE ANALYSIS OF ADVERSE DRUG REACTIONS AMONG OROPHARYNGEAL CANCER PATIENTS RECEIVING DIFFERENT CHEMOTHERAPEUTIC REGIMENS IN KARACHI, SINDH, PAKISTAN
- PRIDE Complex (Papulopustules and/or Paronychia, Regulatory Abnormalities of Hair Growth, Itching, Dryness Due to EGFR Inhibitors)
- Effets secondaires cutanéo-muqueux des nouvelles molécules anticancéreuses: Inhibiteurs de l'EGF-R, inhibiteurs de tyrosine kinase et stabilisateurs du fuseau mitotique
- Perspectives in Head and Neck Medical Oncology
- The ophthalmological complications of targeted agents in cancer therapy: what do we need to know as ophthalmologists?
- Malignant epithelial tumors: Part II. Therapy and prevention
- Chemotherapy-induced iatrogenic injury of skin: New drugs and new concepts
- Dermatologic Reactions to Targeted Therapy
- Hypertrichosis of the pinnae in a patient using panitumumab
- PRIDE syndrome with lumbosacral hypertrichosis
- Efluvio anágeno. Hallazgos tricoscópicos
- Toxic Side Effects of Targeted Therapies and Immunotherapies Affecting the Skin, Oral Mucosa, Hair, and Nails
- Drug-Induced Skin, Nail and Hair Disorders
- Cutaneous reactions to chemotherapeutic drugs and targeted therapy for cancer
- Drug Reactions Affecting Hair: Diagnosis